How does ACTD's PE Ratio compare to its peers?

ACTD is good value based on its Price-To-Earnings Ratio (12.6x) compared to the peer average (22.2x).

How does ACTD's PE Ratio compare vs other companies in the European Chemicals Industry?

ACTD is good value based on its Price-To-Earnings Ratio (12.6x) compared to the European Chemicals industry average (18.7x).

What is ACTD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate ACTD's Price-To-Earnings Fair Ratio for valuation analysis.

What is the Fair Price of ACTD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

ACTD (€51.8) is trading below our estimate of [[fair value]] (€184.46)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

ACTD Stock Overview

Develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details

ACTD fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	3/6
Past Performance	6/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 71.9% below our estimate of its fair value

Earnings are forecast to grow 12.86% per year

Earnings grew by 67.7% over the past year

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

AlzChem Group AG Competitors

Treatt

LSE:TET

UK£273.4m

Johnson Matthey

LSE:JMAT

UK£2.3b

Croda International

LSE:CRDA

UK£4.6b

Iofina

AIM:IOF

UK£36.5m

Price History & Performance

Summary of share price highs, lows and changes for AlzChem Group
Historical stock prices
Current Share Price	€51.80
52 Week High	€0
52 Week Low	€0
Beta	1.01
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	24.82%

Recent updates

Shareholder Returns

	ACTD	GB Chemicals	GB Market
7D	0%	3.7%	3.2%
1Y	n/a	-17.5%	10.9%

Return vs Industry: Insufficient data to determine how ACTD performed against the UK Chemicals industry.

Return vs Market: Insufficient data to determine how ACTD performed against the UK Market.

Price Volatility

Is ACTD's price volatile compared to industry and market?
ACTD volatility
ACTD Average Weekly Movement	n/a
Chemicals Industry Average Movement	5.8%
Market Average Movement	4.8%
10% most volatile stocks in GB Market	10.7%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: ACTD's share price has been volatile over the past 3 months compared to the UK market.

Volatility Over Time: Insufficient data to determine ACTD's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1908	1,607	Andreas Niedermaier	www.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
ACTD fundamental statistics
Market cap	€582.09m
Earnings (TTM)	€46.34m
Revenue (TTM)	€556.77m

12.6x

P/E Ratio

1.0x

P/S Ratio

Is ACTD overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACTD income statement (TTM)
Revenue	€556.77m
Cost of Revenue	€218.93m
Gross Profit	€337.84m
Other Expenses	€291.50m
Earnings	€46.34m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 07, 2024

Earnings per share (EPS)	4.55
Gross Margin	60.68%
Net Profit Margin	8.32%
Debt/Equity Ratio	29.3%

How did ACTD perform over the long term?

See historical performance and comparison

Dividends

2.1%

Current Dividend Yield

26%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/10/15 11:08
End of Day Share Price	2024/07/18 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AlzChem Group AG is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Laura Lopez Pineda	Baader Helvea Equity Research
Konstantin Wiechert	Baader Helvea Equity Research
Knut Woller	Baader Helvea Equity Research

AlzChem Group BATS-CHIXE:ACTD Stock Report